Business

dsm-firmenich Q1 2025 trading update

Press ReleaseKaiseraugst (Switzerland), Maastricht (Netherlands), April 30, 2025 dsm-firmenich Q1 2025 trading update Management Report Q1 2025 highlights Good start to the year with strong organic sales and earnings growthProgressing well on 2025 strategic planSale of Feed Enzymes business for €1.5 billion announcedAnimal Nutrition & Health exit process advancing as planned€1 billion share buyback program commenced in AprilFY 2025 outlook unchanged: Adjusted EBITDA at least €2.4 billion Key fig

articleDsm-firmenich AgApril 30, 202510/company/dsm-firmenich-ag-1/news/dsm-firmenich-q1-2025-trading-update
dsm-firmenich Q1 2025 trading update

About this update from Dsm-firmenich Ag

[{"type":"image","alt":"dsm-firmenich","displaySize":"","headline":null,"caption":"dsm-firmenich","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":58,"url":"https://media.zenfs.com/en/globenewswire.com/9b415d4a2865afc6fd1cf942611724d8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/mMYFeKUNdZU9mGc.nThqBg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTgxO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/9b415d4a2865afc6fd1cf942611724d8","width":300,"height":58}},"lazy":false},{"type":"text","content":"Press ReleaseKaiseraugst (Switzerland), Maastricht (Netherlands), April 30, 2025","length":81,"tagName":"p"},{"type":"text","content":"dsm-firmenich Q1 2025 trading update","length":36,"tagName":"p"},{"type":"text","content":"Management Report","length":17,"tagName":"p"},{"type":"text","content":"Q1 2025 highlights ","length":18,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Good start to the year with strong organic sales and earnings growth","length":68,"tagName":"p"}]},{"val":[{"type":"text","content":"Progressing well on 2025 strategic plan","length":39,"tagName":"p"}]},{"val":[{"type":"text","content":"Sale of Feed Enzymes business for €1.5 billion announced","length":56,"tagName":"p"}]},{"val":[{"type":"text","content":"Animal Nutrition & Health exit process advancing as planned","length":63,"tagName":"p"}]},{"val":[{"type":"text","content":"€1 billion share buyback program commenced in April","length":51,"tagName":"p"}]},{"val":[{"type":"text","content":"FY 2025 outlook unchanged: Adjusted EBITDA at least €2.4 billion","length":64,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":341,"olType":false},{"type":"text","content":"Key figures ","length":11,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"max-width:25%;width:25%;min-width:25%;border-bottom:solid black 1pt;vertical-align:bottom;","val":[{"type":"text","content":"in € millions","length":13,"tagName":"p","attribs":{}}]},{"style":"max-width:25%;width:25%;min-width:25%;border-bottom:solid black 1pt;text-align:right;vertical-align:middle;vertical-align:bottom;","val":[{"type":"text","content":"Q1 2025","length":7,"tagName":"p","attribs":{}}]},{"style":"max-width:25%;width:25%;min-width:25%;border-bottom:solid black 1pt;text-align:right;vertical-align:middle;vertical-align:bottom;","val":[{"type"...

More updates from Dsm-firmenich Ag

EBITDA marginsales growthearnings growthOrganic sales growthorganic sales